CPI-613 is an E1α pyruvate dehydrogenase (PDH) modulator that prevents cancer cells from metabolizing glucose for energy. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer.
Specifications and Purity: ≥98%
MDL Number: MFCD22420826
Molecular Formula: C22H28O2S2
Molecular Weight: 388.59
PubChem CID: 24770514
Isomeric SMILES: C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/C127954-SCI_4436c205a1704c8f2b0bd5701fe3acde.pdf
- UPC:
- 41105001
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- C127954-100mg
- CAS:
- 95809-78-2
- Product Size:
- 100mg
- Hazard Statement Codes:
- H410:H400
- Precautionary Statement Codes:
- P501:P391:P273
akash.verma@cenmed.com
(732) 447-1115





